AMZN
Amazon.com, Inc.
AMZN has the edge over CTRN overall, supported by stronger valuation and lower modeled downside.
CTRN
Citi Trends, Inc.
CTRN's outlook is improving, though it still trails on the overall score.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
CTRN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Stable | |
| Strong |
CTRN's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN has the edge over CTRN in the historical PE scenario, which offers more potential upside but is not a forecast.
CTRN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 3.8x | $3.31 | -92% |
| Fair | 10x | $8.73 | -80% |
| Forward | 19x | $43.05 | — |
| Expensive | 46x | $39.40 | -8.5% |
| Current | 50x | $43.05 | — |
Historical ranges are pointers, not guarantees.
CTRN's PE is in its expensive range at 50x. If earnings grow as analysts expect, today's price would be 19x next year's earnings, in its fair range.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
Analysts expect earnings and revenue growth for AMZN, with profitability improving.
CTRN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| High |
CTRN has the edge over AMZN on the outlook, with more favorable valuation expectations.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the edge over CTRN on earnings, with more consistent year-over-year improvement.
CTRN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.33 | +170% |
| Q3 2026 | $0.86 | +$2.85 |
| Q2 2026 | $1.43 | +$6.09 |
| Q1 2026 | $0.63 | +$5.82 |
| Q4 2025 | -$1.99 | +$1.07 |
| Q3 2025 | -$1.99 | +$0.68 |
| Q2 2025 | -$4.66 | -$3.59 |
| Q1 2025 | -$5.19 | -$3.73 |
| Q4 2024 | -$3.06 | -$2.04 |
CTRN has returned to profit: it earned $0.86 per share over the past year, after losing money the year before.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN has the edge over CTRN on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN has the edge over CTRN on profitability, with a higher operating margin.
CTRN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $211.6M | +11% |
| Q2 2026 | $230.9M | +14% |
| Q1 2026 | $230.4M | +9.1% |
| Q4 2025 | $197.1M | +10% |
| Q3 2025 | $190.8M | +8% |
| Q2 2025 | $201.7M | +8.3% |
| Q1 2025 | $211.2M | -1.9% |
| Q4 2024 | $179.1M | -0.3% |
CTRN's revenue is recovering but still below its 2021 peak: $212M last quarter, up 11% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -0.8% | -2.7 points |
| Q2 2026 | 3.2% | +3 points |
| Q1 2026 | 3.1% | +2.6 points |
| Q4 2025 | -3.7% | +1.2 points |
| Q3 2025 | 1.8% | +16 points |
| Q2 2025 | 0.2% | +4 points |
| Q1 2025 | 0.6% | -1.3 points |
| Q4 2024 | -4.9% | -1.6 points |
CTRN's operating margin was −0.8% last quarter, down 2.7 points from the same quarter a year ago.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
CTRN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$24M | -$22.2M |
| Q2 2026 | $15M | +$28.1M |
| Q1 2026 | $14.7M | -44% |
| Q4 2025 | $767K | +$21.2M |
| Q3 2025 | -$1.7M | -205% |
| Q2 2025 | -$13.1M | +$8.1M |
| Q1 2025 | $26M | +30% |
| Q4 2024 | -$20.4M | -$12.8M |
CTRN has the edge over AMZN on cash generation, producing positive trailing cash flow while its opponent burns cash.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has 10.9B diluted shares, up 0.8% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
CTRN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -3.5% | -301K shares |
| 1 year | -1.6% | -130K shares |
| 3 years | -0.5% | -41.4K shares |
| 5 years | -11% | -995K shares |
| Available history | -30% | -3.5M shares |
CTRN has the edge over AMZN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | $6.3M |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | $4.7M |
| Q2 2022 | $5.3M |
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
CTRN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -2.2x | Net Cash |
| Q2 2026 | -2.7x | Net Cash |
| Q1 2026 | -3.0x | Net Cash |
| Q4 2025 | -3.2x | Net Cash |
| Q3 2025 | -3.5x | Net Cash |
| Q2 2024 | -27.2x | Net Cash |
| Q4 2023 | -20.2x | Net Cash |
| Q3 2023 | -1.6x | Net Cash |
CTRN has the edge over AMZN on leverage, with a lower net debt burden relative to earnings.
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
CTRN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 39.5 | Neutral |
| Stochastic | 6.0 | Oversold |
CTRN's weekly RSI is 39 (neutral) and its Stochastic is 6 (oversold).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN has the edge over CTRN on valuation relative to its sector.
CTRN PE vs Consumer Cyclical Sector
| Metric | CTRN | Sector median | Relative |
|---|---|---|---|
| PE | 50x | 18x | 178% above |
| PE % | 86 | 47 | 39 pts above |
CTRN is trading at 50x earnings, a 178% premium to the Consumer Cyclical sector's median of 18x.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN has the edge over CTRN on trend strength, trading above more of its moving averages.
CTRN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $47.4 | 9.1% below |
| 20 week MA | $57.9 | 26% below |
| 50 week MA | $50.8 | 15% below |
| 100 week MA | $40.1 | 7.4% above |
| 200 week MA | $31.2 | 38% above |
CTRN has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 38% above its 200-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has the edge over CTRN on returns for 2026, with the stronger performance.
CTRN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $22.8 | $47.4 | +108% |
| 2021 | $47.4 | $76.4 | +61% |
| 2022 | $76.4 | $27.6 | -64% |
| 2023 | $27.6 | $28.3 | +2.4% |
| 2024 | $28.3 | $26.9 | -5.1% |
| 2025 | $26.9 | $40.2 | +50% |
| 2026 YTD | $40.2 | $43.1 | +7.2% |
CTRN's yearly returns have swung widely, from +108% in 2020 to −64% in 2022. It's up 7.2% so far in 2026.